Free Trial
NYSEAMERICAN:CCEL

Cryo-Cell International (CCEL) Stock Price, News & Analysis

Cryo-Cell International logo
$4.91 +0.16 (+3.37%)
Closing price 04:10 PM Eastern
Extended Trading
$4.93 +0.02 (+0.41%)
As of 05:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Cryo-Cell International Stock (NYSEAMERICAN:CCEL)

Key Stats

Today's Range
$4.80
$5.25
50-Day Range
$4.75
$5.48
52-Week Range
$4.75
$9.43
Volume
16,903 shs
Average Volume
13,274 shs
Market Capitalization
$39.67 million
P/E Ratio
491.49
Dividend Yield
12.22%
Price Target
$8.50
Consensus Rating
Buy

Company Overview

Cryo-Cell International Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
42nd Percentile Overall Score

CCEL MarketRank™: 

Cryo-Cell International scored higher than 42% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cryo-Cell International is 491.49, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.94.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cryo-Cell International is 491.49, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 20.50.

  • Percentage of Shares Shorted

    0.20% of the float of Cryo-Cell International has been sold short.
  • Short Interest Ratio / Days to Cover

    Cryo-Cell International has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cryo-Cell International has recently increased by 8.11%, indicating that investor sentiment is decreasing significantly.
  • Dividend Leadership

    Cryo-Cell International is a leading dividend payer. It pays a dividend yield of 12.63%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Cryo-Cell International does not have a long track record of dividend growth.

  • Read more about Cryo-Cell International's dividend.
  • Percentage of Shares Shorted

    0.20% of the float of Cryo-Cell International has been sold short.
  • Short Interest Ratio / Days to Cover

    Cryo-Cell International has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cryo-Cell International has recently increased by 8.11%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Cryo-Cell International this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Cryo-Cell International insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    36.86% of the stock of Cryo-Cell International is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 10.44% of the stock of Cryo-Cell International is held by institutions.

  • Read more about Cryo-Cell International's insider trading history.
Receive CCEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cryo-Cell International and its competitors with MarketBeat's FREE daily newsletter.

CCEL Stock News Headlines

CCEL Cryo-Cell International, Inc. - Seeking Alpha
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Cryo-Cell price target lowered to $8.50 from $9 at Maxim
See More Headlines

CCEL Stock Analysis - Frequently Asked Questions

Cryo-Cell International's stock was trading at $6.50 at the start of the year. Since then, CCEL shares have decreased by 24.5% and is now trading at $4.91.

Cryo-Cell International Inc. (NYSEAMERICAN:CCEL) announced its quarterly earnings results on Tuesday, October, 15th. The company reported $0.13 earnings per share for the quarter, beating the consensus estimate of $0.02 by $0.11. The firm had revenue of $8.07 million for the quarter. Cryo-Cell International had a net margin of 0.40% and a negative trailing twelve-month return on equity of 1.07%.

Shares of CCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cryo-Cell International investors own include Meta Platforms (META), Alimera Sciences (ALIM), Crescent Biopharma (CBIO), iClick Interactive Asia Group (ICLK), NVIDIA (NVDA), AcelRx Pharmaceuticals (ACRX) and Aspen Group (ASPU).

Company Calendar

Last Earnings
10/15/2024
Record date for 5/30 Dividend
5/21/2025
Dividend Payable
5/30/2025
Today
7/15/2025
Fiscal Year End
11/30/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NYSEAMERICAN:CCEL
CIK
862692
Employees
90
Year Founded
N/A

Price Target and Rating

High Price Target
$8.50
Low Price Target
$8.50
Potential Upside/Downside
+73.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.06)
Trailing P/E Ratio
491.49
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$400 thousand
Net Margins
0.40%
Pretax Margin
7.92%
Return on Equity
-1.07%
Return on Assets
0.20%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.58
Quick Ratio
0.54

Sales & Book Value

Annual Sales
$31.99 million
Price / Sales
1.24
Cash Flow
$0.19 per share
Price / Cash Flow
26.50
Book Value
($1.64) per share
Price / Book
-2.99

Miscellaneous

Outstanding Shares
8,080,000
Free Float
5,103,000
Market Cap
$39.67 million
Optionable
Not Optionable
Beta
0.64

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NYSEAMERICAN:CCEL) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners